Trials / Completed
CompletedNCT03216408
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients With Moderate to Severe Glabellar Lines
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 504 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with moderate to severe glabellar lines.
Detailed description
Subjects are randomly assigned into the two groups at the ratio of 2:1. The purpose of study is to confirm the non-inferiority of Neuronox to Botox in terms of the efficacy and safety in subjects with moderate to severe glabellar lines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neuronox | |
| DRUG | Botox |
Timeline
- Start date
- 2016-03-30
- Primary completion
- 2016-11-10
- Completion
- 2017-03-07
- First posted
- 2017-07-13
- Last updated
- 2017-07-13
Source: ClinicalTrials.gov record NCT03216408. Inclusion in this directory is not an endorsement.